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INTRODUCTION

METHODS

• Heart Disease remains the leading cause of death,
accounting for 616,067 deaths in 2009 alone

• A retrospective cohort study was performed on 115
patients who received ICDs for primary and
secondary prevention between July 1989 and March
2010

• Implantable cardioverter defibrillators (ICDs)
provide proven reduction in sudden cardiac death
in patients with life-threatening ventricular
tachyarrhythmias
• A significant number of patients however, do not
receive appropriate therapy during the first few
years after implantation

• Single chamber, dual chamber, and biventricular
ICDs were included
• Clinical data collected at the time of ICD
implantation are shown in the TABLE
• CARELINK follow up data were analyzed to classify
the arrhythmia leading to the ICD therapy
• All ICD therapies (ATP or shocks) were adjudicated
as appropriate or inappropriate by two authors

• While landmark studies have focused on predictors
of inappropriate therapies, there has not been as
much focus on predictors of appropriate therapy

• Patients were then divided into two groups: those
with and without appropriate ICD therapies

• This study attempted to identify clinical variables
that may be associated with increased likelihood of
appropriate ICD therapies

• Patients who received appropriate therapies were
divided into two groups: early (< 2 yrs) vs. late
(> 2 yrs)
• Two tailed independent Student’s t-test was
performed on continuous variables, and Fisher’s
exact test was performed on dichotomous variables

OBJECTIVE
• To identify clinical parameters that may be
associated with a higher risk of appropriate ICD
therapies (shock or anti-tachycardia pacing for
ventricular arrhythmias) in a cohort of patients
being remotely monitored with the Medtronic
CARELINK system
• To identify clinical predictors of early vs. late ICD
shocks in patients with appropriate ICD therapies

Variable
Age at ICD Implant (yrs)
Gender (% Male)
ICD Indication (% Primary Prevention)
Prior CABG
Former or Current Smoker
Cardiomyopathy (% Coronary Artery Disease)
Left Ventricular Ejection Fraction
Systolic vs. Diastolic CHF
Heart Failure > NYHA Class 1
Heart Failure > NYHA Class 3
Chronic Atrial Fibrillation
Hypertension
Diabetes Mellitus
Prior CVA/TIA
COPD
Malignancy
S. Creatinine (mg/dl)
Creatinine Clearance
S. Albumin
Anemia at Implant (Hg <11)
Amiodarone Use
Beta Blocker Use
Mean Duration of Follow Up (yrs)
ECG Parameters
HR (bpm)
QRS Duration (ms)
QT Interval (ms)
JT Interval (ms)
QRS Axis (degrees)

No Appropriate Therapy
(n=81)
61.60
60 (74.1%)
55 (67.9%)
29 (35.8%)
37 (45.7%)
41 (50.6%)
0.33
57 (70.4%)
59 (72.8%)
16 (19.8%)
7 (8.6%)
44 (54.3%)
23 (28.4%)
8 (9.9%)
6 (7.4%)
11 (13.6%)
1.16
87.55
3.89
19 (23.5%)
11 (13.6%)
73 (90.1%)
4.8

Appropriate Therapy
(n=34)
62.03
30 (88.2%)
16 (47.1%)
11 (32.4%)
12 (35.3%)
23 (67.6%)
0.36
19 (55.9%)
19 (55.9%)
3 (8.8%)
3 (8.8%)
18 (52.9%)
4 (11.8%)
2 (5.9%)
1 (2.9%)
4 (11.8%)
1.24
77.77
3.74
4 (11.8%)
10 (29.4%)
26 (76.5%)
5.3

73.3
124.6
461.3
337.3
31.9

61.6
134.6
443.4
302.9
6.36

P Value
NS
NS
0.060
NS
NS
0.10
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
0.058
NS
NS
0.004
NS
NS
0.006
NS

RESULTS (TABLE)
ECG Differences Between
Appropriate & Inappropriate ICD
Therapies

• Only ECG resting heart rate (61.6 vs. 73.3 bpm) and
JT interval (337.3 vs. 302.9 ms) were statistically
different between the two groups
• Among the 34 patients who received appropriate
therapies, none of the variables studied were
significantly different in patients who had early vs.
late ICD shocks
• We were unable to identify any clinical, ECG, or
laboratory variables that were associated with
increased risk of appropriate ICD shock

400

Heart Rate (bpm)
Time (ms)

• The most commonly identified arrhythmia in
cardiac arrest patients is ventricular fibrillation,
up to one third of all cardiovascular mortality
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DISCUSSION
• Although differences in HR and the JT interval
were statistically significant in patients who
received appropriate shock vs. those who did not,
these differences are not clinically meaningful
• We did not identify any clinical predictors of early
vs. late ICD shocks
• These data suggest that we may not be able to
improve on current guidelines for patient selection
for ICD implantation

